In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.50. The company’s shares closed yesterday at ...

These are things you'd never see happen under the old signal calling in Cleveland ... a balanced diet to all receivers on the field from new QB1 Jameis Winston. With Ken Dorsey calling plays ...

And on Saturday in New Orleans, she was at it again. This time around, Swift signaled a touchdown with a huge grin on her face. Swift is trying to put all the good vibes into the Caesars Superdome ...

In a crackdown on illegal mobile signal jammers, Delhi police seized a ... Notably, Palika Market and New Lajpat Rai Market are known for selling affordable electronics, including pirated and ...

GSK plc announced new preliminary data for Arexvy (respiratory syncytial virus vaccine, recombinant adjuvanted) in adults aged 18-49 at increased risk for RSV-LRTD due to certain underlying medical ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price target of £15.50. The company’s shares opened today ...

US pharma major GSK (LSE: GSK) yesterday announced new preliminary data for Arexvy (respiratory syncytial virus vaccine, recombinant adjuvanted) in adults aged 18-49 at increased risk for RSV-LRTD due ...

As such, the party’s acting president Amira Aisya Abd Aziz unveiled the party’s new logo - where the word “Muda” is now in yellow. “After three years (since the party was registered), we ...

The conflicting stands signal continued deep resistance on both ... Hezbollah said Friday it planned to launch a new phase of fighting by sending more guided missiles and exploding drones into ...

JERUSALEM (AP) — Hamas confirmed Friday that its leader, Yahya Sinwar, was killed by Israeli forces in Gaza and reiterated its stance that hostages the militant group took from Israel a year ago ...

London-based GSK is crossing the pond to form a new lung disease research collaboration with Boston scientists. The Big Pharma is joining forces with researchers from the Center for Regenerative ...

"It is a shifting of bets," he said, adding that this routine trimming of jobs here and there is the new normal — for now ... or ask for one of our reporter's Signal numbers.